At a glance
ClinicalIndex Comparison RecordN/AUnknown· 200 target
Drug / intervention
Biopsy, open or laparoscopic surgeryprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Single-cell Sequencing and Establishment of Cell Lines, Organoids, and Transplanted Tumor Models in Neuroendocrine Neoplasm
In Brief
An observational study evaluating Biopsy, open or laparoscopic surgery for Neuroendocrine Neoplasm. Targeting 200 participants across 1 site.
Detailed Summary
The aim of this study is to use single-cell sequencing technology to explore neuroendocrine neoplasm (NEN) molecular biological characteristics, tumor heterogeneity and cell subtypes. Besides. NEN models are constructed for basic research, including primary cell lines, organoids, and animal models.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNeuroendocrine Neoplasm
CountriesChina
CollaboratorsD1 Medical Technology (Shanghai) Co., Ltd, China
Timeline
N/AUnknownOverdue
20222023202420252026
Enrollment StartJun 2021
First PostedJun 2021
Primary CompletionJun 2022
Study CompletionDec 2022
TodayJul 2026
First PostedJun 16, 2021
Enrollment StartJun 6, 2021
Primary CompletionJun 1, 2022
Study CompletionDec 1, 2022
TodayJul 1, 2026
Enrollment to primary: 12 monthsPosted 5.0 years ago
Interventions
Biopsy, open or laparoscopic surgeryprocedure
Collect NEN and PDAC biopsy or surgical fresh tissue to conduct single cell sequencing or model construction.